NIH's Secret Grant Review Meetings Set for July—Eyes Only
Published Date: 6/12/2025
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in July 2025 to review and evaluate important grant and contract proposals. These meetings protect private info and trade secrets while deciding who gets funding for exciting health research. Scientists and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public participation or new costs.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 0 costs, 2 mixed.
Closed NIH Grant Review Meetings
If you are a scientist or organization applying for NIH grants, note that the Center for Scientific Review will hold closed virtual meetings on July 7 and July 9–11, 2025 to review and evaluate grant and contract proposals. These meetings will decide funding outcomes, do not involve public participation, and are virtual.
Small Business Grant Panels Scheduled
If you are a small business applying for NIH small business grants, panels titled 'Small Business: Social and Community Influences Across the Lifecourse' (July 10–11, 2025) and 'Small Business: Instrumentation, Environmental, and Occupational Safety' (July 11, 2025) will meet virtually to review and evaluate your applications. These panels are closed to the public and will influence award decisions.
Applicant Confidentiality Protected
The meetings will be closed under 5 U.S.C. 552b(c)(4) and 552b(c)(6) to protect confidential trade secrets, commercial property (such as patentable material), and personal information of individuals associated with grant applications. This protects applicants' sensitive information during the July 2025 reviews.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16683, Proposed Collection; 60-Day Comment Request; Data Use Certification for the NIH National Institute on Drug Abuse Data Share Site
The purpose of this notice is to inform the public of the information collection requirement for the NIDA Data Share, the data use terms and conditions, and to request a progress report statement at the time of renewal. In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-16544, Government-Owned Inventions; Availability for Licensing
The inventions listed below are owned by an agency of the U.S. Government and are available for licensing to achieve expeditious commercialization of results of federally-funded research for the benefit of the public health.
2026-16440, NIH Owned Invention Available for License: Soluble Tissue Factor, a Novel Target, and Antibodies, for Diagnosis, Prevention and Treatment of Thrombosis and Related Conditions
Scientists at the National Cancer Institute (NCI) have discovered a novel therapeutic, diagnostic and prognostic target for thrombosis: Soluble Tissue Factor (sTF). NCI has generated first-in- class antibodies and platform selectively neutralizing pathological coagulation while preserving normal hemostasis. This platform technology can be used to prevent, diagnose and treat pathological thrombosis caused by a variety of clinical conditions-including cancer, sepsis, infectious diseases (e.g., COVID), autoimmune disorders, trauma, heart conditions and inflammatory conditions. It offers a much more sensitive and specific test of thrombosis than the current D-dimer test. It may be applicable to any clinical condition which induces necroptosis, pyroptosis and NETtosis, such as cancer, neurodegenerative disease, ischemia-reperfusion and acute injuries, traumatic injuries, bacterial and viral infections, cardiovascular conditions, and atherosclerosis, inflammatory, autoimmune conditions, and others.
2026-16071, Proposed Collection; 60-Day Comment Request: The Impact of Clinical Research Training and Medical Education at the Clinical Center on Physician Careers in Academia and Clinical Research (Clinical Center)
In compliance with the requirement of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the Clinical Center, the National Institutes of Health (NIH) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval.
2026-15565, Proposed Collection; 60-Day Comment Request, Data Use Certification for the NIH Brain Development Cohorts (NBDC) Data Hub, (National Institute on Drug Abuse)
In compliance with the requirement of the Paperwork Reduction Act of 1995 to provide opportunity for public comment on proposed data collection projects, the National Institute on Drug Abuse (NIDA) will publish periodic summaries of proposed projects to be submitted to the Office of Management and Budget (OMB) for review and approval. The purpose of this revision is to update instructions for the Research Data Use Statement and the Progress Report, and to add new instructions for attesting to National Institute of Standards & Technology (NIST) security compliance, and for a Project Close-out at the time of project completion. Burden levels remain unchanged.
2026-14966, Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a new Ebola vaccine invention for companies to license and develop quickly. This vaccine targets the Bundibugyo virus and promises fast and lasting protection, helping stop outbreaks in Central Africa. Businesses interested in licensing should act soon to bring this life-saving tech to market and can contact NIH for details.
Previous / Next Documents
Previous: 2025-10688, Atlantic Highly Migratory Species; Schedules for Atlantic Shark Identification Workshops and Protected Species Safe Handling, Release, and Identification Workshops
If you’re a fisherman or shark dealer with federal permits, you’ve got to join free shark ID and safe handling workshops this summer and fall 2025 to keep your permits valid. These workshops teach you how to spot sharks and handle them safely, plus there’s a new online option for recertification. More free sessions will pop up later in 2025, so stay tuned!
Next: 2025-10691, National Human Genome Research Institute; Amended Notice of Meeting
The National Human Genome Research Institute updated its June 18, 2025 meeting details, changing the time to noon–4 PM and providing a new virtual link for online attendance. This meeting is open to everyone, whether you join in person or from your couch. If you’re interested in human genome research, mark your calendar and get ready to tune in or show up!